Medscape Education | Pathology & Lab Medicine

My WebMD Sign In

Please enter email address

Enter your password

Keep me signed in on this computer

If you select "Keep me signed in on this computer", every time you visit WebMD.com you won't have to type your email address and password. This means that a cookie will stay on your computer even when you exit or close your browser which may reduce your levels of privacy and security. You should never select this option if you're using a publicly accessible computer, or if you're sharing a computer with others. Even if you select this option there are some features of our site that still require you to log in for privacy reasons.

Forget your password? Having trouble signing in?

Why should I
sign up for WebMD?

With a WebMD Account you can:

Track your way to weight loss success
Manage your family's vaccinations
Join the conversation

See more benefits Sign Up

Why WebMD?

My WebMD

Show Menu

Facebook Twitter Pinterest

Breast Cancer

Classical/Non-Malignant Hematology

CNS Cancer

Gastrointestinal Cancers

Genitourinary Cancers

Melanoma and Other Skin Cancers

STOP AND THINK...
Could it be a rare disease?

Latest In Pathology & Lab Medicine

Filter

All U.S. Non-U.S.

Lung Cancer 5000186 global 1 1.25 2 1.25 3 1.25 9 1.25 Hematology-Oncology CME / ABIM MOC / CE 1.25 Roundtable 0 1

Targeted Therapy for Mutations

Can you keep up with all the targetable mutations in non-small cell lung cancer (NSCLC)? Start activity

View Details

1.25Credits 75 MIN

Prostate Cancer 3003438 global 1 1.25 2 1.25 3 1.25 9 1.25 Hematology-Oncology CME / ABIM MOC / CE 1.25 Roundtable 0 1

Expanding Therapeutic Options in De Novo Metastatic Hormone-Sensitive Prostate Cancer: Overcoming Resistance to Traditional Therapies

An expert panel delves into the nuances of care for expanding therapeutic options for patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC). Start activity

Expanding Therapeutic Options in De Novo Metastatic Hormone-Sensitive Prostate Cancer: Overcoming Resistance to Traditional Therapies

View Details

1.25Credits 75 MIN

0 global 1 0.75 2 0.75 3 0.75 9 0.75 Hematology-Oncology CME / ABIM MOC / CE 0.75 Roundtable 0 1

Antibody Drug Conjugates

Get the most up to date information on antibody drug conjugates (ADCs) in non-small cell lung cancer (NSCLC)! Start activity

View Details

0.75Credits 45 MIN

Hepatocellular Carcinoma 3032322 global 1 0.50 9 0.50 Hematology-Oncology CME / ABIM MOC 0.5 Roundtable 0 1

Targets and Their Therapies: Unraveling the Targetable Mutations in Cholangiocarcinoma

How are you identifying patients with cholangiocarcinoma who may have IDH1M or FGFR2 alterations who may benefit from targeted therapies? Start activity

View Details

0.5Credits 30 MIN

Urticaria and Angioedema 6006612 global 1 1.0 2 1.0 3 1.0 Dermatology CME / CE 1.0 Clinical Review 0 2

From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria

Are you aware of new and emerging therapies for patients with chronic spontaneous urticaria (CSU)? Find out more here! Start activity

View Details

1.0Credits 60 MIN

Lung Cancer 5000186 global 1 1.00 2 1.00 3 1.00 9 1.00 Hematology-Oncology CME / ABIM MOC / CE 1.0 Roundtable 0 1

Targeted Therapy for Fusions

How are the identification of gene fusions in non-small cell lung cancer (NSCLC) changing treatment? Start activity

View Details

1.0Credits 60 MIN

View All

Curated Collections

Curated activities and resources from our partners and committee

View All

Topics

Credits

Format

Type

Featured Topics